UnitedHealth Group Incorporated (NYSE:UNH) is Penn Davis Mcfarland Inc.’s 8th Largest Position

Penn Davis Mcfarland Inc. lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 21.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 67,547 shares of the healthcare conglomerate’s stock after acquiring an additional 12,085 shares during the quarter. UnitedHealth Group makes up about 3.7% of Penn Davis Mcfarland Inc.’s holdings, making the stock its 8th biggest holding. Penn Davis Mcfarland Inc.’s holdings in UnitedHealth Group were worth $34,169,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the third quarter worth approximately $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares during the period. West Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth $32,000. Quarry LP grew its stake in UnitedHealth Group by 132.1% in the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 37 shares in the last quarter. Finally, RPg Family Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter worth about $37,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $510.03 on Monday. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $549.37 and a 200 day simple moving average of $563.18. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market capitalization of $469.37 billion, a price-to-earnings ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company posted $5.83 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the stock. Morgan Stanley cut their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, January 15th. Barclays decreased their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday. Bank of America decreased their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, KeyCorp restated an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday. Two analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.